Positiveid Corp. (PSID) 0.0300 $PSID
PositiveID Accelerates Prototype Development of Its Firefly Dx System for Real-Time Molecular Diagnostic Testing
GlobeNewswire - Tue Sep 23, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB
SID), a developer of biological detection and diagnostics solutions, today announced that it is accelerating the prototype development of its Firefly Dx system, a handheld, real-time PCR (polymerase chain reaction) system designed to provide molecular diagnostic results in less than 20 minutes at the point of need. To advance the development, PositiveID has engaged Infinite Vision, an engineering development and contract manufacturing firm specializing in medical and biotech products.
PositiveID Analyst Coverage Continued; Brief Report by Small Cap Traders
PR Newswire - Wed Sep 10, 6:30AM CDT
Small Cap Traders analyst report by Michael Anderegg, CFA. PositiveID Corp. (OTCQB: PSID) based in Delray Beach, Fla. and Pleasanton, CA is an emerging player in the BioThreat detection market and has garnered increasing attention as the recent high visibility Ebola outbreak has exploded. Since a Company update disclosing the issuance of revenue guidance through the end of 2015 of $4-10 million (combined between 2014 and 2015), the Company subsequently reported earnings in August featuring the Company's first ever revenue from operations and the smallest operating loss in Company History. A number of metrics were hit in 1H14 that have established traction and begun to build momentum for what is expected to be a strong 2H of the year for PSID.
PositiveID's M-BAND Systems Shipped to Aberdeen Proving Ground for Continued Testing to Protect U.S. Military
GlobeNewswire - Tue Sep 09, 7:00AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has shipped three M-BAND (Microfluidic-based Bioagent Autonomous Networked Detector) systems to Aberdeen Proving Ground ("APG" in Maryland for continued testing to protect U.S. warfighters as part of The Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR) program. APG is recognized as one of the world's most important research and development, testing and evaluation facilities for military weapons and equipment, and supports military and civilian scientists, research engineers, technicians and administrators.
PositiveID Corporation to Present at the Rodman & Renshaw Global Investment Conference
GlobeNewswire - Tue Sep 02, 8:57AM CDT
PositiveID Corporation ("PositiveID" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the Rodman & Renshaw 16th Annual Global Investment Conference taking place September 8-10, 2014, at the New York Palace Hotel in New York City. The Company's presentation is scheduled for 2:55 p.m. on September 9, 2014, and will also be available via webcast at: http://wsw.com/webcast/rrshq24/psid.
PositiveID announces publication of Handheld Bio-Threat Testing Device Firefly Dx system in Computerworld
M2 - Mon Aug 25, 6:07AM CDT
Biological detection company PositiveID (Other OTC SID) revealed on Friday that its Firefly Dx system was recently featured in Computerworld.
PositiveID's Handheld Bio-Threat Testing Device Featured in Computerworld
GlobeNewswire - Fri Aug 22, 7:30AM CDT
PositiveID's Firefly prototype device could be used to detect viruses such as Ebola and other bio-threats
PositiveID's M-BAND System Shipped to Korea for Testing to Protect U.S. Military
GlobeNewswire - Wed Aug 20, 7:00AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its M-BAND (Microfluidic-based Bioagent Autonomous Networked Detector) system has been sent to the Korean peninsula for continued testing as part of The Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR), a program led by the Joint Program Executive Office for Chemical and Biological Defense and supported by the U.S. Army Edgewood Chemical Biological Center, to provide unique biological detection capabilities for advanced bio-surveillance on the Korean peninsula.
PositiveID Corporation Reports Revenue From Continuing Operations for First Time in Its History
GlobeNewswire - Fri Aug 15, 7:01AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced it has reported revenue and its smallest operating loss from continuing operations for the first time in the Company's history. The Company's Form 10-Q for the quarter ended June 30, 2014, can be found at: http://investors.positiveidcorp.com/secfiling...IK=1347022.
PositiveID Corporation to Exhibit at the 2014 Military Health System Research Symposium Conference on August 18-21
GlobeNewswire - Wed Aug 13, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it will exhibit at the 2014 Military Health System Research Symposium (MHSRS) Conference on August 18-21, 2014, at the Marriott Harbour Beach Resort in Fort Lauderdale, FL.
Ebola Outbreak Escalates Urgency and Spikes Visibility for Emerging Contender in Biothreat Detection -- PositiveID Corp. Investor Update by SmallCapTraders.com
PR Newswire - Thu Aug 07, 3:01PM CDT
PositiveID Corp. (OTCQB: PSID), with offices in Delray Beach, FL and Pleasanton, CA, is an emerging player in the biothreat detection market. The recent high visibility Ebola outbreak has created significant alarm among government officials as well as industry experts with a steady stream of media coverage flowing out over the last several days as the public follows the story closely. A number of industry experts and potential contenders in the market for diagnostic testing products have surfaced with various opinions and potential solutions with varying degrees of applicability to the near term problem at hand; preventing uncontrolled spread of Ebola (and other bio-threats) that could result in a pandemic or other major public health crisis.
PositiveID's Firefly Dx System Featured on Fox News San Francisco
GlobeNewswire - Thu Aug 07, 9:41AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Firefly Dx system, designed to deliver molecular diagnostic results rapidly at the point-of-need, which could be used for quick Ebola detection, was featured on the Fox news San Francisco affiliate. The clip can be viewed at: http://m.ktvu.com/news/news/health-med-fit-sc...tes/ngxFP/
PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com
PR Newswire - Wed Jul 23, 8:30AM CDT
PositiveID Corp. (OTCQB: PSID), based in Delray Beach, Fla., is an emerging player in the bio-threat detection market, that develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security ("DHS" Science & Technology directorate, and $30 million of contract funding.
PositiveID wins new purchase order to support M-BAND System for US government to protect the nation's warfighters and defenders
M2 - Fri Jul 18, 9:56AM CDT
Biological detection company PositiveID (Other OTC SID) disclosed on Thursday the receipt of a new purchase order for the continued testing and evaluation of its M-BAND (Microfluidic Bioagent Autonomous Networked Detector) from a large government contractor in support of an existing US government contract.
PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
GlobeNewswire - Thu Jul 17, 6:11AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has received a new order from a large government contractor for the continued testing and evaluation of PositiveID's M-BAND (Microfluidic Bioagent Autonomous Networked Detector) in support of an existing U.S. government contract. In keeping with contractual obligations the contractor and program have not been named. As a result of this new purchase order, the company has increased its 2014/2015 revenue and backlog (backlog added to revenue recognized) estimate from $3.3 million to $3.5 million, and is reiterating its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined).
PositiveID Corp. Chairman and CEO William J. Caragol Conducts New Interview with The Green Baron Report
GlobeNewswire - Tue Jul 01, 7:11AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that its Chairman and CEO William J. Caragol has conducted a new, audio-taped webcast interview with The Green Baron Report. In the interview, Mr. Caragol provides an update for PositiveID's stockholders and the investment community on the Company's recent developments and growth plans. Unrestricted access to the webcast is now available on the "Webcasts" page at http://www.thegreenbaron.com/Webcasts.htm .
PositiveID Publishes Updated Report on Its BioThreat Detection and Diagnostics Solutions and Market Opportunities
GlobeNewswire - Mon Jun 30, 6:00AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today published an updated report on its 2014 progress and future market opportunities for its homeland security and medical diagnostics technologies.
Quality Systems Teams Up With 3M Health Information Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:50PM CDT
Quality Systems (QSII) continues to report a fall in earnings and revenues but we are still optimistic about the company given the continued strength in its NextGen subsidiary as well as the expected benefit from its Mirth acquisition.
Cerner Enters New Agreement with North Carolina's Mission Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:40PM CDT
Under the new agreement, signed on Mar 28, Cerner Corporation (CERN) will help Mission Health control IT costs, align strategies, and improve the quality of care.
St. Jude Medical Hits New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 2:45PM CDT
Considering the last one month, shares of St. Jude Medical (STJ) returned 8.9%, higher than the S&P 500 return of 5.0%.
St. Jude Medical Gets Award for Leadless Pacemaker - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 12:10PM CDT
A congress committee of electrophysiologists has chosen St. Jude Medical's (STJ) Nanostim leadless pacemaker for the award being the most innovative product in electrophysiology and cardiac technique
PositiveID Accelerates Prototype Development of Its Firefly Dx System for Real-Time Molecular Diagnostic Testing
GlobeNewswire - Tue Sep 23, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it is accelerating the prototype development of its Firefly Dx system, a handheld, real-time PCR (polymerase chain reaction) system designed to provide molecular diagnostic results in less than 20 minutes at the point of need. To advance the development, PositiveID has engaged Infinite Vision, an engineering development and contract manufacturing firm specializing in medical and biotech products. PositiveID Analyst Coverage Continued; Brief Report by Small Cap Traders
PR Newswire - Wed Sep 10, 6:30AM CDT
Small Cap Traders analyst report by Michael Anderegg, CFA. PositiveID Corp. (OTCQB: PSID) based in Delray Beach, Fla. and Pleasanton, CA is an emerging player in the BioThreat detection market and has garnered increasing attention as the recent high visibility Ebola outbreak has exploded. Since a Company update disclosing the issuance of revenue guidance through the end of 2015 of $4-10 million (combined between 2014 and 2015), the Company subsequently reported earnings in August featuring the Company's first ever revenue from operations and the smallest operating loss in Company History. A number of metrics were hit in 1H14 that have established traction and begun to build momentum for what is expected to be a strong 2H of the year for PSID.
PositiveID's M-BAND Systems Shipped to Aberdeen Proving Ground for Continued Testing to Protect U.S. Military
GlobeNewswire - Tue Sep 09, 7:00AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has shipped three M-BAND (Microfluidic-based Bioagent Autonomous Networked Detector) systems to Aberdeen Proving Ground ("APG" in Maryland for continued testing to protect U.S. warfighters as part of The Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR) program. APG is recognized as one of the world's most important research and development, testing and evaluation facilities for military weapons and equipment, and supports military and civilian scientists, research engineers, technicians and administrators. PositiveID Corporation to Present at the Rodman & Renshaw Global Investment Conference
GlobeNewswire - Tue Sep 02, 8:57AM CDT
PositiveID Corporation ("PositiveID"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the Rodman & Renshaw 16th Annual Global Investment Conference taking place September 8-10, 2014, at the New York Palace Hotel in New York City. The Company's presentation is scheduled for 2:55 p.m. on September 9, 2014, and will also be available via webcast at: http://wsw.com/webcast/rrshq24/psid. PositiveID announces publication of Handheld Bio-Threat Testing Device Firefly Dx system in Computerworld
M2 - Mon Aug 25, 6:07AM CDT
Biological detection company PositiveID (Other OTC
SID) revealed on Friday that its Firefly Dx system was recently featured in Computerworld. PositiveID's Handheld Bio-Threat Testing Device Featured in Computerworld
GlobeNewswire - Fri Aug 22, 7:30AM CDT
PositiveID's Firefly prototype device could be used to detect viruses such as Ebola and other bio-threats
PositiveID's M-BAND System Shipped to Korea for Testing to Protect U.S. Military
GlobeNewswire - Wed Aug 20, 7:00AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its M-BAND (Microfluidic-based Bioagent Autonomous Networked Detector) system has been sent to the Korean peninsula for continued testing as part of The Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR), a program led by the Joint Program Executive Office for Chemical and Biological Defense and supported by the U.S. Army Edgewood Chemical Biological Center, to provide unique biological detection capabilities for advanced bio-surveillance on the Korean peninsula. PositiveID Corporation Reports Revenue From Continuing Operations for First Time in Its History
GlobeNewswire - Fri Aug 15, 7:01AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced it has reported revenue and its smallest operating loss from continuing operations for the first time in the Company's history. The Company's Form 10-Q for the quarter ended June 30, 2014, can be found at: http://investors.positiveidcorp.com/secfiling...IK=1347022. PositiveID Corporation to Exhibit at the 2014 Military Health System Research Symposium Conference on August 18-21
GlobeNewswire - Wed Aug 13, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it will exhibit at the 2014 Military Health System Research Symposium (MHSRS) Conference on August 18-21, 2014, at the Marriott Harbour Beach Resort in Fort Lauderdale, FL. Ebola Outbreak Escalates Urgency and Spikes Visibility for Emerging Contender in Biothreat Detection -- PositiveID Corp. Investor Update by SmallCapTraders.com
PR Newswire - Thu Aug 07, 3:01PM CDT
PositiveID Corp. (OTCQB: PSID), with offices in Delray Beach, FL and Pleasanton, CA, is an emerging player in the biothreat detection market. The recent high visibility Ebola outbreak has created significant alarm among government officials as well as industry experts with a steady stream of media coverage flowing out over the last several days as the public follows the story closely. A number of industry experts and potential contenders in the market for diagnostic testing products have surfaced with various opinions and potential solutions with varying degrees of applicability to the near term problem at hand; preventing uncontrolled spread of Ebola (and other bio-threats) that could result in a pandemic or other major public health crisis.
PositiveID's Firefly Dx System Featured on Fox News San Francisco
GlobeNewswire - Thu Aug 07, 9:41AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Firefly Dx system, designed to deliver molecular diagnostic results rapidly at the point-of-need, which could be used for quick Ebola detection, was featured on the Fox news San Francisco affiliate. The clip can be viewed at: http://m.ktvu.com/news/news/health-med-fit-sc...tes/ngxFP/ PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com
PR Newswire - Wed Jul 23, 8:30AM CDT
PositiveID Corp. (OTCQB: PSID), based in Delray Beach, Fla., is an emerging player in the bio-threat detection market, that develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security ("DHS"
Science & Technology directorate, and $30 million of contract funding. PositiveID wins new purchase order to support M-BAND System for US government to protect the nation's warfighters and defenders
M2 - Fri Jul 18, 9:56AM CDT
Biological detection company PositiveID (Other OTC
SID) disclosed on Thursday the receipt of a new purchase order for the continued testing and evaluation of its M-BAND (Microfluidic Bioagent Autonomous Networked Detector) from a large government contractor in support of an existing US government contract. PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
GlobeNewswire - Thu Jul 17, 6:11AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has received a new order from a large government contractor for the continued testing and evaluation of PositiveID's M-BAND (Microfluidic Bioagent Autonomous Networked Detector) in support of an existing U.S. government contract. In keeping with contractual obligations the contractor and program have not been named. As a result of this new purchase order, the company has increased its 2014/2015 revenue and backlog (backlog added to revenue recognized) estimate from $3.3 million to $3.5 million, and is reiterating its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined). PositiveID Corp. Chairman and CEO William J. Caragol Conducts New Interview with The Green Baron Report
GlobeNewswire - Tue Jul 01, 7:11AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that its Chairman and CEO William J. Caragol has conducted a new, audio-taped webcast interview with The Green Baron Report. In the interview, Mr. Caragol provides an update for PositiveID's stockholders and the investment community on the Company's recent developments and growth plans. Unrestricted access to the webcast is now available on the "Webcasts" page at http://www.thegreenbaron.com/Webcasts.htm . PositiveID Publishes Updated Report on Its BioThreat Detection and Diagnostics Solutions and Market Opportunities
GlobeNewswire - Mon Jun 30, 6:00AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today published an updated report on its 2014 progress and future market opportunities for its homeland security and medical diagnostics technologies. Quality Systems Teams Up With 3M Health Information Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:50PM CDT
Quality Systems (QSII) continues to report a fall in earnings and revenues but we are still optimistic about the company given the continued strength in its NextGen subsidiary as well as the expected benefit from its Mirth acquisition.
Cerner Enters New Agreement with North Carolina's Mission Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:40PM CDT
Under the new agreement, signed on Mar 28, Cerner Corporation (CERN) will help Mission Health control IT costs, align strategies, and improve the quality of care.
St. Jude Medical Hits New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 2:45PM CDT
Considering the last one month, shares of St. Jude Medical (STJ) returned 8.9%, higher than the S&P 500 return of 5.0%.
St. Jude Medical Gets Award for Leadless Pacemaker - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 12:10PM CDT
A congress committee of electrophysiologists has chosen St. Jude Medical's (STJ) Nanostim leadless pacemaker for the award being the most innovative product in electrophysiology and cardiac technique
